Adriamycin Injection
Brand Name: ADRIAMYCIN® Ready-to-Use
Composition: Doxorubicin Hydrochloride Injection I.P.
Manufacturer: Pfizer
Product Description
Medical Info
ADRIAMYCIN® Ready-to-Use, manufactured by Pfizer, contains 50 mg of Doxorubicin Hydrochloride per 25ml, adhering to Indian Pharmacopoeia (I.P.) standards. This medication is a cytotoxic anthracycline antibiotic primarily indicated for chemotherapy regimens to treat various malignancies, including acute leukemias, lymphomas, soft tissue sarcomas, and solid tumors like breast, ovarian, and bladder cancer. It works by intercalating DNA and inhibiting topoisomerase II, thereby disrupting cancer cell replication. Packaged as a sterile, ready-to-use solution, it requires strict specialized handling and must be administered exclusively under the close supervision of a qualified oncology expert.
Storage & Safety
Precautions & Warnings
Reconstitute only with the prescribed quantity of clean drinking water. Shake well before each use. Complete the full course as prescribed. Discard any unused suspension after 7 days of reconstitution.
Storage
Store in a cool, dry place below 25°C. Protect from light and moisture. Refrigeration after reconstitution is preferred.
Status
Keep all medicines out of reach of children.
